Typing of Helicobacter Pylori with Monoclonal Antibodies Against Lewis Antigens in Lipopolysaccharide
Overview
Authors
Affiliations
Recently, it has been shown that the lipopolysaccharide (LPS) O antigen of Helicobacter pylori contains Lewis x (Lex), Lewis y (Ley), or both Lex and Ley antigens. We applied a serotyping method for H. pylori by an enzyme-linked immunosorbent assay with monoclonal antibodies (MAbs) specific for these antigens and the related fucosylated H type 1 (H1) antigen. The selected MAbs recognized the Lex and/or Ley structures in the LPS of H. pylori. The agreement between the results of biochemical compositional analysis and the serological data validated our serotyping system. A total of 152 strains from different geographic origins (The Netherlands, Canada, Poland, Italy, and People's Republic of China) were examined for typeability based on the presence of Lewis antigens. One hundred twenty-nine (84.9%) strains were typeable, and 12 different serotyping patterns were observed; 80.9% of the strains contained Lex and/or Le(y) antigens, and 18.4% reacted with the MAb against the related H1 antigen either alone or in combination with the Lex and/or Ley antigen. Our results show that the Lex and Ley antigens are frequently encountered in the LPS of H. pylori strains from various geographic origins. This typing method is an easy-to-perform technique, which can be used for strain differentiation in epidemiological studies of H. pylori infections.
glycan biosynthesis modulates host immune cell recognition and response.
Barrett K, Kassama F, Surks W, Mulholland A, Moulton K, Dube D Front Cell Infect Microbiol. 2024; 14:1377077.
PMID: 38572314 PMC: 10987845. DOI: 10.3389/fcimb.2024.1377077.
Lipopolysaccharide O-antigen profiles of Helicobacter pylori strains from Southwest China.
Tang X, Wang P, Shen Y, Song X, Benghezal M, Marshall B BMC Microbiol. 2023; 23(1):360.
PMID: 37993791 PMC: 10664510. DOI: 10.1186/s12866-023-03116-0.
Anti-Glycan Autoantibodies Induced by as a Potential Risk Factor for Myocardial Infarction.
Negrini R, Villanacci V, Poiesi C, Savio A Front Immunol. 2020; 11:597.
PMID: 32322255 PMC: 7158853. DOI: 10.3389/fimmu.2020.00597.
Gonciarz W, Walencka M, Moran A, Hinc K, Obuchowski M, Chmiela M J Biomed Sci. 2019; 26(1):23.
PMID: 30841890 PMC: 6402143. DOI: 10.1186/s12929-019-0515-z.
Diagnosis of Using Invasive and Noninvasive Approaches.
Talebi Bezmin Abadi A J Pathog. 2018; 2018:9064952.
PMID: 29951318 PMC: 5987299. DOI: 10.1155/2018/9064952.